Flow Cytometry

流式细胞仪

基本信息

  • 批准号:
    10617298
  • 负责人:
  • 金额:
    $ 23.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-06-17 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Flow Cytometry Core: Project Summary/Abstract Flow cytometry is an essential method in cancer research. It is widely used to identify, track and purify specific cell populations through analysis of cell surface markers and/or fluorescent reporter genes, and also to assess cellular phenotypes, such as cell cycle progression, DNA damage or apoptosis responses. Flow cytometry also supports a broad range of engineering-based approaches, such as quantification of targeting efficiencies for antibody- and copolymer-based therapeutic delivery systems, and high-throughput approaches to develop fluorophore-based protein labeling and imaging technology. The Koch Institute Flow Cytometry Core is a Shared Resource that provides Center Members with training in, and access to, state-of-the-art cell sorting instrumentation, technical expertise and training, and data analyses. In the current period, the capabilities of this Core were further expanded and enhanced. Two new analyzers and two new sorters were acquired, replacing older obsolete instrumentation, and three systems were upgraded with new lasers to expand detection capabilities. Core service usage by Center Member has remained high (93% of Center Members). In addition, using CCSG Developmental Funds, the Core has supported a Research Specialist who has established a suite of single cell-associated technologies, including a collaboration with the Koch Institute Integrated Genomics & Bioinformatics Core to enable high throughput single cell mRNA sequencing. These services are now well-developed services within the Core, and we seek continued, partial funding to support the Research Specialist’s efforts. In the upcoming period, the Flow Cytometry Core will continue to offer a wide range of state-of-the-art services to support the research programs of Center Members and will evaluate emerging capabilities in the context of Center Member needs and interests. The Core intends to evaluate high parameter cell sorting, addition of robotics capabilities for automated sampling, mass cytometry, and multiplexed ion beam imaging. The Core will also expand training opportunities, including hands-on data analysis workshops. This Shared Resource is essential to the success of the Koch Institute mission and provides exceptional value to the CCSG because Koch Institute Members account for 84% of the Core services usage. The requested CCSG budget for Year 49 is increased by 9.2% over the budget in the current period (Year 48), reflecting the request for additional funding to stabilize support for the new single cell analysis capabilities.
流式细胞术核心:项目摘要/摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Birnbaum其他文献

Michael Birnbaum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Birnbaum', 18)}}的其他基金

Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
使用 CAR 和肽-MHC 嵌合抗原配体精确靶向 T1D 特异性 T 细胞
  • 批准号:
    10436483
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
使用 CAR 和肽-MHC 嵌合抗原配体精确靶向 T1D 特异性 T 细胞
  • 批准号:
    10621960
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
Development of an emulsion-based method for repertoire-scale paired-chain T cell receptor sequencing
开发基于乳剂的全谱配对链 T 细胞受体测序方法
  • 批准号:
    10371136
  • 财政年份:
    2021
  • 资助金额:
    $ 23.25万
  • 项目类别:
Repertoire-scale T cell antigen identification via peptide-MHC lentivirus display
通过肽-MHC 慢病毒展示进行全库规模 T 细胞抗原鉴定
  • 批准号:
    10001123
  • 财政年份:
    2020
  • 资助金额:
    $ 23.25万
  • 项目类别:
Determining antigen recognition in systemic sclerosis
确定系统性硬化症中的抗原识别
  • 批准号:
    10188400
  • 财政年份:
    2014
  • 资助金额:
    $ 23.25万
  • 项目类别:
Determining antigen recognition in systemic sclerosis
确定系统性硬化症中的抗原识别
  • 批准号:
    9915867
  • 财政年份:
  • 资助金额:
    $ 23.25万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 23.25万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 23.25万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了